PHYSICIANS and PATIENTS

Nometics is developing cancer therapies based on the restoration of the nitric oxide signaling pathway.

Neither Health Canada nor the U.S. Food and Drug Administration have approved any of our products at this time.,

Patients and physicians have inquired about:

A. Clinical Trials

i - No clinical trials are currently open for recruitment

ii - Nometics is a Canadian company and does not currently conduct trials in the US

iii - As appropriate, we will update trial status on this website and will register U.S. clinical trials on www.clintrials.gov

B: PRODUCT AVAILABILITY-

NOVade™ is not currently available for purchase in any jurisdiction.